Weight-loss drug pioneer announces €432m investment to build pill plant in Athlone – The Irish Times
Weight-loss drug pioneer Novo Nordisk will invest €432 million in upgrading its Athlone plant to produce the tablet…
Novo Nordisk’s CagriSema study shows 20 percent weight loss, but doesn’t beat tirzepatide
Novo Nordisk today announced headline results from REDEFINE 4, an open-label phase 3 trial from the global REDEFINE…
Novo Nordisk set to make Wegovy pill in Ireland for markets outside US – The Irish Times
Wight loss drug company Novo Nordisk will expand its facility in Athlone, chief executive Mike Doustdar says. The…
Novo Nordisk Launches Suit to Knock Out Hims & Hers’ Weight Loss Knockoffs
Novo Nordisk wants Hims & Hers to get theirs. On Monday, the Danish pharmaceutical giant made good on…
Upbeat forecast from Lilly on weight loss drugs adds to Novo Nordisk gloom as it foresees steep drop in sales – The Irish Times
Shares in weight loss drug giants Novo Nordisk and Eli Lilly moved in sharply different directions on Wednesday…